Granules India

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE101D01020
NSEID: GRANULES
BSEID: 532482

INR

557.00

-9.55 (-1.69%)

BSENSE

Dec 05

BSE+NSE Vol: 1.69 lacs

{
  "main_header": {
    "sid": 580033,
    "name": "Granules India",
    "stock_name": "Granules India",
    "full_name": "Granules India Ltd",
    "name_url": "stocks-analysis/granules-india",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "557.00",
    "chg": -9.55,
    "chgp": "-1.69%",
    "dir": -1,
    "prev_price": "566.55",
    "mcapval": "13,516.65 Cr",
    "mcap": "Small Cap",
    "scripcode": 532482,
    "symbol": "GRANULES",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE101D01020",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "1.69 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/granules-india-580033-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Granules India Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/granules-india-upgraded-to-buy-on-strong-technicals-and-solid-financial-metrics-3740515",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GranulesIndia_mojoScore_3740515.png",
        "date": "2025-12-02 08:14:14",
        "description": "Granules India, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, reflecting a complex interplay of technical indicators, valuation metrics, financial trends, and quality parameters. This article analyses the factors influencing the recent shift in the company’s assessment and what it means for investors navigating the current market landscape."
      },
      {
        "title": "Granules India Technical Momentum Shifts Signal Market Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/granules-india-technical-momentum-shifts-to-bullish-amid-mixed-market-returns-3740108",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GranulesIndia_technicaldot_3740108.png",
        "date": "2025-12-02 08:06:41",
        "description": "Granules India has exhibited a notable shift in its technical momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. Recent price movements and technical indicators suggest a transition towards a more bullish stance, highlighting investor attention amid broader market trends."
      },
      {
        "title": "How has been the historical performance of Granules India?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-granules-india-3739187",
        "imagepath": "",
        "date": "2025-12-01 23:03:41",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profitability Trends</strong></p>\n<p>Granules India's net sales have shown a robust upward trend over the past six years, rising from ₹2,279.20 crores in March 2019 to ₹4,481.61 crores in March 2025. The company experienced significant growth between 2019 and 2021, with sales increasing by over 40% in two years, reflecting strong market demand and operational expansion. However, sales plateaued around ₹4,500 crores in the subsequent years, indicating a stabilisation phase.</p>\n<p>Operating profit margins, excluding other income, have fluctuated notably. The margin peaked at 26.42% in March 2021 but moderated to 21.21% by March 2025. This variation suggests periods of cost pressure or strategic investments impacting profitability. Despite this, the operating profit (PBDIT) rose fr..."
      },
      {
        "title": "Why is Granules India falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-granules-india-fallingrising-3726635",
        "imagepath": "",
        "date": "2025-11-25 00:33:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Performance and Market Context</strong></p>\n<p>Granules India’s share price has been on a downward trajectory over the past week, falling by 5.34%, significantly underperforming the Sensex, which remained almost flat with a marginal decline of 0.06% during the same period. The one-month trend mirrors this weakness, with the stock down 5.32% while the Sensex gained 0.82%. Year-to-date, the stock has declined by 10.20%, contrasting sharply with the Sensex’s robust 8.65% gain. Even over the last year, Granules India’s shares have fallen by 4.81%, whereas the benchmark index rose by 7.31%. These figures highlight a persistent underperformance relative to the broader market.</p>\n<p>Despite this short-term weakness, the stock has delivered strong returns over a longer horizon, with a ..."
      },
      {
        "title": "Granules India Evaluation Revised Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/granules-india-downgraded-to-hold-by-marketsmojo-amid-mixed-technical-and-financial-signals-3717210",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/GranulesIndia_mojoScore_3717210.png",
        "date": "2025-11-20 08:05:09",
        "description": "Granules India, a key player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market assessment following a detailed analysis of its quality, valuation, financial trends, and technical indicators. This reassessment reflects a nuanced view of the company’s current position amid fluctuating market conditions and sectoral dynamics."
      },
      {
        "title": "How has been the historical performance of Granules India?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-granules-india-3716156",
        "imagepath": "",
        "date": "2025-11-19 22:40:54",
        "description": "Answer:\nGranules India has shown a varied historical performance over the years, with net sales reaching 4,481.61 Cr in March 2025, slightly down from 4,506.37 Cr in March 2024 and 4,511.92 Cr in March 2023. The total operating income mirrored this trend, remaining stable around 4,481.61 Cr in March 2025. The raw material costs decreased significantly to 1,724.94 Cr in March 2025 from 2,208.22 Cr in March 2024, contributing to a total expenditure of 3,536.37 Cr in March 2025. Operating profit (PBDIT) increased to 958.16 Cr in March 2025, up from 860.38 Cr in March 2024, while profit before tax also rose to 660.17 Cr from 547.23 Cr in the previous year. However, profit after tax saw a slight decline to 501.52 Cr in March 2025 from 516.60 Cr in March 2023. The earnings per share (EPS) improved to 20.68 in March 2025 from 16.72 in March 2024. On the balance sheet, total assets grew to 6,184.73 Cr in March 2025..."
      },
      {
        "title": "Why is Granules India falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-granules-india-fallingrising-3712871",
        "imagepath": "",
        "date": "2025-11-18 21:56:34",
        "description": "As of 18-Nov, Granules India Ltd is currently priced at 561.00, reflecting a decrease of 0.45 (-0.08%). The stock has outperformed its sector today by 0.54%, and it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. However, there is a notable decline in investor participation, with delivery volume falling by 21.88% against the 5-day average. Over the past week, the stock has increased by 4.86%, but it has seen a decline of 1.26% over the past month and a year-to-date drop of 5.20%. Despite a positive return of 6.01% over the past year, the company faces challenges with poor long-term growth, as evidenced by its net sales and operating profit growth rates over the last five years.\n\nIn the broader market context, Granules India has outperformed the Sensex by 3.90% over the past week, while the benchmark has shown a modest increase of 0.96%. The stock's high institutional holdin..."
      },
      {
        "title": "Is Granules India technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-granules-india-technically-bullish-or-bearish-3710216",
        "imagepath": "",
        "date": "2025-11-18 08:29:51",
        "description": "As of 17 November 2025, the technical trend for Granules India has changed from bullish to mildly bullish. The weekly MACD remains bullish, while the monthly MACD is mildly bearish, indicating mixed signals across time frames. The Bollinger Bands are bullish on the weekly chart and mildly bullish on the monthly chart, supporting a positive outlook. Daily moving averages are bullish, reinforcing the mildly bullish stance. However, the weekly KST is bullish, and the monthly KST is mildly bearish, adding to the mixed sentiment. The Dow Theory shows a mildly bearish trend on the weekly chart, with no trend on the monthly chart. Overall, the current technical stance is mildly bullish, driven primarily by the bullish daily moving averages and weekly MACD, despite some bearish signals on the monthly indicators...."
      },
      {
        "title": "Granules India Faces Mixed Technical Signals Amidst Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/granules-indias-technical-trend-changes-from-bullish-to-mildly-bullish-amid-mixed-indicators-3710493",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/GranulesIndia_technicaldot_3710493.png",
        "date": "2025-11-18 08:11:19",
        "description": "Granules India, a small-cap pharmaceutical company, has recently seen a stock price adjustment amid changing market conditions. While it has underperformed compared to the Sensex over the past year, its long-term performance remains strong, with significant returns over the last decade, reflecting its resilience in the market."
      }
    ],
    "total": 417,
    "sid": "580033",
    "stock_news_url": "https://www.marketsmojo.com/news/granules-india-580033"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "01-Dec-2025",
      "details": "Press Release",
      "source": "BSE"
    },
    {
      "caption": "Updates",
      "datetime": "27-Nov-2025",
      "details": "Updates",
      "source": "BSE"
    },
    {
      "caption": "Transcript Of The Earnings Conference Call For Q2 And The Half-Year Of FY26.",
      "datetime": "19-Nov-2025",
      "details": "Transcript of the Earnings Conference Call for Q2 and the half-year of FY26.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Granules India Ltd has declared <strong>150%</strong> dividend, ex-date: 31 Jul 25",
          "dt": "2025-07-31",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Granules India Ltd has announced <strong>1:10</strong> stock split, ex-date: 23 Mar 15",
          "dt": "2015-03-23",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Granules India Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals

2025-12-02 08:14:14

Granules India, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, reflecting a complex interplay of technical indicators, valuation metrics, financial trends, and quality parameters. This article analyses the factors influencing the recent shift in the company’s assessment and what it means for investors navigating the current market landscape.

Granules India Technical Momentum Shifts Signal Market Interest

2025-12-02 08:06:41

Granules India has exhibited a notable shift in its technical momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. Recent price movements and technical indicators suggest a transition towards a more bullish stance, highlighting investor attention amid broader market trends.

How has been the historical performance of Granules India?

2025-12-01 23:03:41

Revenue and Profitability Trends

Granules India's net sales have shown a robust upward trend over the past six years, rising from ₹2,279.20 crores in March 2019 to ₹4,481.61 crores in March 2025. The company experienced significant growth between 2019 and 2021, with sales increasing by over 40% in two years, reflecting strong market demand and operational expansion. However, sales plateaued around ₹4,500 crores in the subsequent years, indicating a stabilisation phase.

Operating profit margins, excluding other income, have fluctuated notably. The margin peaked at 26.42% in March 2021 but moderated to 21.21% by March 2025. This variation suggests periods of cost pressure or strategic investments impacting profitability. Despite this, the operating profit (PBDIT) rose fr...

Why is Granules India falling/rising?

2025-11-25 00:33:42

Recent Price Performance and Market Context

Granules India’s share price has been on a downward trajectory over the past week, falling by 5.34%, significantly underperforming the Sensex, which remained almost flat with a marginal decline of 0.06% during the same period. The one-month trend mirrors this weakness, with the stock down 5.32% while the Sensex gained 0.82%. Year-to-date, the stock has declined by 10.20%, contrasting sharply with the Sensex’s robust 8.65% gain. Even over the last year, Granules India’s shares have fallen by 4.81%, whereas the benchmark index rose by 7.31%. These figures highlight a persistent underperformance relative to the broader market.

Despite this short-term weakness, the stock has delivered strong returns over a longer horizon, with a ...

Granules India Evaluation Revised Amid Mixed Financial and Technical Signals

2025-11-20 08:05:09

Granules India, a key player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market assessment following a detailed analysis of its quality, valuation, financial trends, and technical indicators. This reassessment reflects a nuanced view of the company’s current position amid fluctuating market conditions and sectoral dynamics.

How has been the historical performance of Granules India?

2025-11-19 22:40:54

Answer: Granules India has shown a varied historical performance over the years, with net sales reaching 4,481.61 Cr in March 2025, slightly down from 4,506.37 Cr in March 2024 and 4,511.92 Cr in March 2023. The total operating income mirrored this trend, remaining stable around 4,481.61 Cr in March 2025. The raw material costs decreased significantly to 1,724.94 Cr in March 2025 from 2,208.22 Cr in March 2024, contributing to a total expenditure of 3,536.37 Cr in March 2025. Operating profit (PBDIT) increased to 958.16 Cr in March 2025, up from 860.38 Cr in March 2024, while profit before tax also rose to 660.17 Cr from 547.23 Cr in the previous year. However, profit after tax saw a slight decline to 501.52 Cr in March 2025 from 516.60 Cr in March 2023. The earnings per share (EPS) improved to 20.68 in March 2025 from 16.72 in March 2024. On the balance sheet, total assets grew to 6,184.73 Cr in March 2025...

Why is Granules India falling/rising?

2025-11-18 21:56:34

As of 18-Nov, Granules India Ltd is currently priced at 561.00, reflecting a decrease of 0.45 (-0.08%). The stock has outperformed its sector today by 0.54%, and it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. However, there is a notable decline in investor participation, with delivery volume falling by 21.88% against the 5-day average. Over the past week, the stock has increased by 4.86%, but it has seen a decline of 1.26% over the past month and a year-to-date drop of 5.20%. Despite a positive return of 6.01% over the past year, the company faces challenges with poor long-term growth, as evidenced by its net sales and operating profit growth rates over the last five years. In the broader market context, Granules India has outperformed the Sensex by 3.90% over the past week, while the benchmark has shown a modest increase of 0.96%. The stock's high institutional holdin...

Is Granules India technically bullish or bearish?

2025-11-18 08:29:51

As of 17 November 2025, the technical trend for Granules India has changed from bullish to mildly bullish. The weekly MACD remains bullish, while the monthly MACD is mildly bearish, indicating mixed signals across time frames. The Bollinger Bands are bullish on the weekly chart and mildly bullish on the monthly chart, supporting a positive outlook. Daily moving averages are bullish, reinforcing the mildly bullish stance. However, the weekly KST is bullish, and the monthly KST is mildly bearish, adding to the mixed sentiment. The Dow Theory shows a mildly bearish trend on the weekly chart, with no trend on the monthly chart. Overall, the current technical stance is mildly bullish, driven primarily by the bullish daily moving averages and weekly MACD, despite some bearish signals on the monthly indicators....

Granules India Faces Mixed Technical Signals Amidst Market Evaluation Revision

2025-11-18 08:11:19

Granules India, a small-cap pharmaceutical company, has recently seen a stock price adjustment amid changing market conditions. While it has underperformed compared to the Sensex over the past year, its long-term performance remains strong, with significant returns over the last decade, reflecting its resilience in the market.